NCT01010620

Brief Summary

The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
523

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2009

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 10, 2009

Completed
21 days until next milestone

Study Start

First participant enrolled

December 1, 2009

Completed
9.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

August 19, 2019

Status Verified

August 1, 2019

Enrollment Period

9.5 years

First QC Date

July 8, 2009

Last Update Submit

August 15, 2019

Conditions

SchizophreniaSubstance AbuseCocaine AbuseTobacco Use Disorder

Keywords

screeningresearch participationsubstance abuseSchizophrenianicotineHealthycigarettessmokingmarijuanacocaine

Outcome Measures

Primary Outcomes (1)

  • Recruitment of participants into NIDA/MPRC protocols.

    5 years

Secondary Outcomes (1)

  • Demographic characterization of drug users, non-users, and individuals with serious mental illnesses contacting NIDA/MPRC about research participation

    5 year

Study Arms (1)

Screening

Screening Assessment battery. Specific to study(or studies) the individual is screening for.

Behavioral: Various Screening psychiatric and medical assessments

Interventions

Various Screening psychiatric and medical assessmentsBEHAVIORAL

Possibly blood draws, urine samples, toxicology screens, computer-based and written psychological, psychiatric, and behavioral questionnaires and assessments.

Screening

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Population will see an advertisement in the community and call the NIDA call center. If they appear to meet the qualifications for one or more NIDA/MPRC studies, they will be scheduled to be screened.

You may qualify if:

  • Age 18 or older
  • Ability to read and understand and answer questions posed.

You may not qualify if:

  • Inability to provide valid informed consent
  • Below Age 18, and above age 64.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maryland Psychiatric Research Center

Catonsville, Maryland, 21228, United States

Location

MeSH Terms

Conditions

SchizophreniaSubstance-Related DisordersCocaine-Related DisordersTobacco Use DisorderSmokingMarijuana Abuse

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersChemically-Induced DisordersBehavior

Study Officials

  • Deanna L Kelly, Pharm.D., BCPP

    University of Maryland, College Park

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deanna L. Kelly, PharmD., BCPP Professor of Psychiatry Director, Treatment Research Program (TRP)

Study Record Dates

First Submitted

July 8, 2009

First Posted

November 10, 2009

Study Start

December 1, 2009

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

August 19, 2019

Record last verified: 2019-08

Locations

US(1)